Russell Investments Group
LYEL icon

Russell Investments Group’s Lyell Immunopharma LYEL Stock Holding History

Russell Investments Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
+752
New +$13.6K ﹤0.01% 3922
2024
Q3 		– Sell
-574
Closed -$16.6K – 3748
2024
Q2 		$16.6K Buy
574
+403
+236% +$19.2K ﹤0.01% 2972
2024
Q1 		$7.62K Buy
+171
New +$7.32K ﹤0.01% 2884
2023
Q3 		– Sell
-1,065
Closed -$67.7K – 3583
2023
Q2 		$67.7K Sell
1,065
-2,472
-70% -$137K ﹤0.01% 2676
2023
Q1 		$167K Buy
+3,537
New +$189K ﹤0.01% 2506

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Russell Investments Group's LYEL Position: Q2 2026 in Review

Russell Investments Group opened a new position in Lyell Immunopharma (LYEL) in Q2 2026: 752 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #3922 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in LYEL as recently as Q2 2024.

Russell Investments Group first reported a position in LYEL in Q1 2023 and has held it in 5 quarters since. The position peaked at $167K in Q1 2023. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Russell Investments Group held 752 shares of Lyell Immunopharma worth $10.6K as of Q2 2026.
  • Lyell Immunopharma was a new Russell Investments Group position in Q2 2026.
  • Lyell Immunopharma made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3922 holding.
  • Russell Investments Group first reported a position in Lyell Immunopharma in Q1 2023 and has held it in 5 quarters since.
  • Russell Investments Group's Lyell Immunopharma position peaked at $167K in Q1 2023.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.